| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -76,344 | 100% | $250.61 | -$19,132,570 |
| Net | -8 | -76,344 | -100% | -$19,132,570 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Richard C. Breeden | Director | $13,782,370 | 13 Aug 2025 | ||
| Daniel A. Carestio | President and CEO, Director | $12,356,034 | -$4,313,788 | -25.9% | 06 Oct 2025 |
| MICHAEL J. TOKICH | Sr. Vice Pres., CFO | $11,440,139 | 04 Jun 2025 | ||
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | $8,926,998 | -$4,454,681 | -33.3% | 11 Nov 2025 |
| JACQUELINE B. KOSECOFF | Director | $7,961,064 | 08 Aug 2024 | ||
| Mohsen Sohi | Director | $7,480,046 | -$994,456 | -11.7% | 08 Aug 2025 |
| CYNTHIA L. FELDMANN | Director | $4,201,168 | -$844,252 | -16.7% | 08 Aug 2025 |
| Cary L. Majors | SVP and President, Healthcare | $3,241,522 | -$3,208,026 | -49.7% | 01 Oct 2025 |
| Mary Clare Fraser | SVP & Chief HRO | $3,094,508 | 01 Oct 2025 | ||
| Julia Madsen | Sr. VP and GM, Life Sciences | $2,806,020 | -$1,312,096 | -31.9% | 21 Nov 2025 |
| Richard Martin Steeves | Director | $2,305,692 | 08 Aug 2024 | ||
| Karen L. Burton | Sr. Vice Pres., CFO | $1,994,783 | -$1,909,667 | -48.9% | 01 Oct 2025 |
| DAVID B. LEWIS | Director | $1,642,981 | 21 Jul 2021 | ||
| Kenneth E. Kohler | Svp & Gm, Ast | $1,640,469 | 04 Jun 2025 | ||
| Nirav R. Shah | Director | $1,560,367 | 08 Aug 2025 | ||
| Renato Tamaro | V.P. & Corporate Treasurer | $1,467,943 | -$2,095,605 | -58.8% | 18 Nov 2025 |
| Andrew Xilas | SVP and GM, Dental | $1,414,619 | 31 May 2024 | ||
| Paul Edward Martin | Director | $1,095,148 | 08 Aug 2025 | ||
| Esther M. Alegria | Director | $543,230 | 08 Aug 2025 | ||
| CHRISTOPHER S. HOLLAND | Director | $139,494 | 08 Aug 2025 | ||
| Louis Shapiro | Director | 08 Aug 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|